News

ascopubs.org

Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Absence of Biallelic TCRγ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia Chemotherapy-naive patients with GI tract cancers scheduled for ...
BioWorld

Onquality receives IND clearance for OQL-036 for capecitabine-induced hand-foot syndrome

Onquality Pharmaceuticals LLC has received FDA clearance of its IND application for OQL-036, a potential prophylactic treatment for capecitabine-induced hand-foot syndrome (HFS).
ascopubs.org

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial

Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...
Nature

Chemotherapy-Induced Hand-Foot Syndrome and Skin Reactions

Chemotherapy-induced hand-foot syndrome (HFS) is a common and distressing side effect experienced by patients undergoing cancer treatment. This condition, also known as palmar-plantar ...